Nath Bio-Genes (India) Limited (NATHBIOGEN.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In INR
| Market Cap | 2.56B |
| Enterprise Value | 3.19B |
| P/E Ratio | 8.64 |
| PEG Ratio | -0.76 |
| Price/Sales Ratio | 0.62 |
| Price/Book Ratio | 0.44 |
| Enterprise/Revenue | 0.75 |
| Enterprise/EBITDA | 5.95 |
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.08 |
| Operating Margin | 0.09 |
| Return On Assets | 0.04 |
| Return On Equity | 0.06 |
| Revenue | 4.45B |
| Revenue/Share | 257.74 |
| Gross Profit | 2.04B |
| EBITDA | 662.56M |
| Net Income | 416.3M |
| Diluted EPS | 20.98 |
| Total Cash | 759.95M |
| Total Cash/Share | 39.99 |
| Total Debt | 1.39B |
| Total Debt/Equity | 0.2 |
| Current Ratio | 1.97 |
| Book Value Per Share | 358.06 |
| 52-Week Change | -11.32 |
| 52-Week High | 204 |
| 52-Week Low | 126.15 |
| Moving Average 50 Days | 166.54 |
| Moving Average 200 Days | 158.12 |
| Average Volume | 28,933 |
| Shares Outstanding | 19M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 2 |
| Trailing Annual Dividend Yield | 1.26 |
| Payout Ratio | 0.1 |
| Last Split Factor | N/A |
| Last Split Date | N/A |